Skip to content

Transcultural Validation of MSTS and TESS Questionnaire

Transcultural Validation of MSTS and TESS Questionnaire

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03765970
Acronym
MSTS-TESS
Enrollment
250
Registered
2018-12-05
Start date
2019-01-21
Completion date
2019-12-31
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Tumor resection, MSTS, TESS, Soft tissue and bone, Questionnaires

Brief summary

Reference treatment for soft tissue or bone sarcoma is the Monobloc resection surgery, with a margin of one to many millimeters removing the entire tumor leaving no cancer cells, associated or not with other treatments. Other musculoskeletal malignant tumors, some of them with secondary origins (metastases), are treated the same way. Patients with soft tissue and bone tumor could have heavy sequels of this surgery procedure, depending on the localization and size of the initial tumor. Those functional sequels are evaluated by specific questionnaires: the questionnaire TESS for upper limbs and TESS for lower limbs which are completed by the patient (depending on the localization of the tumor) and the questionnaire MSTS which is completed by the medical doctor. Those English validated questionnaires are frequently used by French surgeons in standard practice as well as scientific research. The translations done have never been validated by an official methodology. The aim of this trial is to validate the TESS and MSTS questionnaires linguistically, culturally (questions must be adapted for each target population: occidental adults and adolescents population, male and female population and adapted to the current era), and scientifically (repeatability). The validation of those questionnaires will permit to have functional and reference questionnaires in French language which could be used for the follow up of operated patient in the context of the care and clinical research.

Detailed description

The methodology will follow the guidelines of Dorcas E. Beaton, Claire Bombardier, Francis Guillemin and Marcos Bosi Ferraz (approved in particular by the American Academy of Orthopedic Surgeons): Step 1: Author's agreement Step 2: Translation with cultural adaptation in addition to literal translation Step 3: 2 first translations English to French (2 different translators T1 and T2) Step 4: Synthesis (T12) Step 5: 2 reverse translations of T12 French to English (BT1 and BT2) Step 6: Submission to a committee of experts of the final translation Step 7: Clinical study based on a sample of patients (questionnaires, interview and analysis of the distribution of responses) The investigators planned the recruitment of 250 adults and adolescents patients over 15 years old, who will answers to the questionnaires (MSTS-TESS) as well as control-questionnaires (WOMAC or DASH) during a follow-up consultation, in Nantes, Rennes, Tours or Marseille centers. A study of repeatability will be performed with 30 to 50 patients for whom 2 filling will be necessary, the first time during the consultation and the second time at home, 15 days later.

Interventions

None listed

Sponsors

University Hospital, Angers
CollaboratorOTHER_GOV
Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major Patients who has accepted and be informed of the protocol or minor patient over 15 years old who has accepted and be informed of the protocol, with the agreement of one legal representative * Patients over 15 years old who had a surgical procedure for a musculoskeletal tumor which could result in functional sequels. (at the appreciation of the surgeon) * Patients in the capacity to answer and understand the questionnaire and for whom the French is the native language

Exclusion criteria

* Patients refusing to participate * Patient under guardianship * Patient inappropriate for entry into this study according to the judgment of the investigator

Design outcomes

Primary

MeasureTime frame
Validation of psychometric properties of questionnaire MSTS in French translationone day

Secondary

MeasureTime frameDescription
Define face validity : evaluate the comprehension of the questionnaire by 5 to 10 patients (qualitative analysis)one day
Define questionnaires construction validity: coherent evolution of scoring with the clinical status of the patients (ANOVA)3 months (after study completion)
Define criteria validity: coherence with other scores (correlation with WOMAC-long form >0.4)one day
Define questionnaires content validity : evaluation of translation quality (expert consensus).one dayAfter the 2 translations and retrotranslations of the questionnaires adapted to the present time and the target population, an expert committee composed of health professionals meets with the aim of proposing a unified version. This latest version is subject to the approval of the original authors.
Verify the repeatability of the questionnaire MSTS on 30 to 50 patients : concordance between answers of two surgeons on the same consultationone day
Define criteria validity for upper limbs: coherence with DASH score (correlation with DASH >0.4)one day
Verify the repeatability of the questionnaire TESS on 30 to 50 patients: concordance between answers of the same patient completing twice the same questionnaires (first during the consultation and then 15 days after at home).two weeks
Define score reliability: intern coherence and responses coherence (Cronbach's alpha > 0.7 and Loevinger's H > 0.3)3 months (after study completion)

Countries

France

Contacts

Primary ContactKevin BRULEFERT, Dr
Kevin.brulefert@chu-nantes.fr0240082211

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026